Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 33

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα

Cao, Baohua, Lu, Tsan-Wen, Martinez Fiesco, Juliana A., Tomasini, Michael, Fan, Lixin, Simon, Sanford M., Taylor, Susan S., Zhang, Ping · 2019 · Structure

Published version of a preprint

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2019.03.001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 57

  1. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. Sect. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  2. Amieux, 2002, The essential role of RI alpha in the maintenance of regulated PKA activity, Ann. N. Y. Acad. Sci., 968, 75, 10.1111/j.1749-6632.2002.tb04328.x · DOI · Paper page
  3. Amieux, 1997, Compensatory regulation of RIα protein levels in protein kinase A mutant mice, J. Biol. Chem., 272, 3993, 10.1074/jbc.272.7.3993 · DOI · Paper page
  4. Badireddy, 2011, Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.004390 · DOI
  5. Barros, 2017, Electrostatic interactions as mediators in the allosteric activation of protein kinase A RIα, Biochemistry, 56, 1536, 10.1021/acs.biochem.6b01152 · DOI
  6. Boettcher, 2011, Realizing the allosteric potential of the tetrameric protein kinase A RIα holoenzyme, Structure, 19, 265, 10.1016/j.str.2010.12.005 · DOI
  7. Bowers, K.J., Chow, D.E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., Klepeis, J.L., Kolossvary, I., Moraes, M.A., Sacerdoti, F.D., et al. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In ACM/IEEE SC 2006 Conference (SC’06), (IEEE), pp. 43. · DOI · Paper page
  8. Brown, 2009, Novel isoform-specific interfaces revealed by PKA RIIβ holoenzyme structures, J. Mol. Biol., 393, 1070, 10.1016/j.jmb.2009.09.014 · DOI
  9. Bruystens, 2014, PKA RIα homodimer structure reveals an intermolecular interface with implications for cooperative cAMP binding and Carney complex disease, Structure, 22, 59, 10.1016/j.str.2013.10.012 · DOI · Paper page
  10. Cheng, 2009, Sensing domain dynamics in protein kinase A-Iα complexes by solution X-ray scattering, J. Biol. Chem., 284, 35916, 10.1074/jbc.M109.059493 · DOI
  11. Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc. Natl. Acad. Sci. U S A, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
  12. Cook, 1982, Adenosine cyclic 3’,5’-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 · DOI · Paper page
  13. Craig, 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
  14. Darcy, 2015, The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients, Oncotarget, 6, 755, 10.18632/oncotarget.2712 · DOI · Paper page
  15. Eggert, 2013, Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10, Gut, 62, 1667, 10.1136/gutjnl-2013-305164 · doi:10.1136/gutjnl-2013-305164
  16. El-Serag, 2004, Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study, Hepatology, 39, 798, 10.1002/hep.20096 · DOI
  17. Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. Sect. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  18. Engelholm, 2017, CRISPR/Cas9 engineering of adult mouse liver demonstrates that the Dnajb1-Prkaca gene fusion is sufficient to induce tumors resembling fibrolamellar hepatocellular carcinoma, Gastroenterology, 153, 1662, 10.1053/j.gastro.2017.09.008 · DOI
  19. Graham, 2017, Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI · Paper page
  20. Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum. Mutat., 29, 633, 10.1002/humu.20688 · DOI
  21. Harder, 2016, OPLS3: a force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput., 12, 281, 10.1021/acs.jctc.5b00864 · DOI · Paper page
  22. Hirakis, 2017, Molecular simulations reveal an unresolved conformation of the type IA protein kinase a regulatory subunit and suggest its role in the cAMP regulatory mechanism, Biochemistry, 56, 3885, 10.1021/acs.biochem.7b00461 · DOI
  23. Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  24. Ilouz, 2012, Localization and quaternary structure of the PKA RIβ holoenzyme, Proc. Natl. Acad. Sci. U S A, 109, 12443, 10.1073/pnas.1209538109 · DOI
  25. Kakar, 2005, Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis, Mod. Pathol., 18, 1417, 10.1038/modpathol.3800449 · doi:10.1038/modpathol.3800449
  26. Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, Proc. Natl. Acad. Sci. U S A, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
  27. Katzenstein, 2003, Fibrolamellar hepatocellular carcinoma in children and adolescents, Cancer, 97, 2006, 10.1002/cncr.11292 · DOI
  28. Kim, 2007, PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
  29. Lalazar, 2018, Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms, Semin. Liver Dis., 38, 51, 10.1055/s-0037-1621710 · DOI · Paper page
  30. Li, 2000, Consequences of cAMP and catalytic-subunit binding on the flexibility of the A-kinase regulatory subunit, Biochemistry, 39, 15626, 10.1021/bi002196l · DOI
  31. Lim, 2014, Advances in fibrolamellar hepatocellular carcinoma: a review, Eur. J. Pediatr. Surg., 24, 461, 10.1055/s-0034-1396420 · doi:10.1055/s-0034-1396420
  32. Linglart, 2012, PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance, J. Clin. Endocrinol. Metab., 97, E2328, 10.1210/jc.2012-2326 · DOI
  33. Martyna, 1992, Nosé-Hoover chains: the canonical ensemble via continuous dynamics, J. Chem. Phys., 97, 2635, 10.1063/1.463940 · DOI · Paper page
  34. Mavros, 2012, A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma, J. Am. Coll. Surg., 215, 820, 10.1016/j.jamcollsurg.2012.08.001 · DOI
  35. McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  36. Murshudov, 2011, REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr. D Biol. Crystallogr., 67, 355, 10.1107/S0907444911001314 · DOI · Paper page
  37. Oikawa, 2015, Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells, Nat. Commun., 6, 8070, 10.1038/ncomms9070 · DOI
  38. Otwinowski, 1997, [20] Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X · DOI · Paper page
  39. Park, 2012, Novel mutation in PRKAR1A in Carney complex, Korean J. Pathol., 46, 595, 10.4132/KoreanJPathol.2012.46.6.595 · DOI
  40. Riggle, 2016, Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma, Pediatr. Res., 80, 110, 10.1038/pr.2016.36 · DOI · Paper page
  41. Riggle, 2016, Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma, Pediatr. Blood Cancer, 63, 1163, 10.1002/pbc.25970 · DOI · Paper page
  42. Simon, 2015, Transcriptomic characterization of fibrolamellar hepatocellular carcinoma, Proc. Natl. Acad. Sci. U S A, 112, E5916, 10.1073/pnas.1424894112 · DOI · Paper page
  43. Søberg, 2017, Evolution of the cAMP-dependent protein kinase (PKA) catalytic subunit isoforms, PLoS One, 12, e0181091, 10.1371/journal.pone.0181091 · DOI
  44. Svergun, 1992, Determination of the regnlarization parameter in indirect-transform methods using perceptual criteria, J. Appl. Crystallogr., 25, 495, 10.1107/S0021889892001663 · DOI · Paper page
  45. Svergun, 1995, CRYSOL – a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates, J. Appl. Crystallogr., 28, 768, 10.1107/S0021889895007047 · DOI · Paper page
  46. Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
  47. Terracciano, 2004, Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis, Arch. Pathol. Lab. Med., 128, 222, 10.5858/2004-128-222-FHCOYA · doi:10.5858/2004-128-222-fhcoya
  48. Torbenson, 2012, Fibrolamellar carcinoma: 2012 update, Scientifica (Cairo), 2012, 743790
  49. Tuckerman, 2006, A Liouville-operator derived measure-preserving integrator for molecular dynamics simulations in the isothermal-isobaric ensemble, J. Phys. A Math. Gen., 39, 5629, 10.1088/0305-4470/39/19/S18 · DOI · Paper page
  50. Veugelers, 2004, Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice, Proc. Natl. Acad. Sci. U S A, 101, 14222, 10.1073/pnas.0405535101 · DOI
  51. Weeda, 2013, Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience, Eur. J. Cancer, 49, 2698, 10.1016/j.ejca.2013.04.012 · DOI
  52. Wu, 2004, Crystal structures of RIα subunit of cyclic adenosine 5′-monophosphate (cAMP)-dependent protein kinase complexed with (R p)-adenosine 3′,5′-cyclic monophosphothioate and (S p)-adenosine 3′,5′-cyclic monophosphothioate, the phosphothioate analogues of cAMP, Biochemistry, 43, 6620, 10.1021/bi0302503 · DOI
  53. Wu, 2004, RIalpha subunit of PKA: a cAMP-free structure reveals a hydrophobic capping mechanism for docking cAMP into site B, Structure, 12, 1057, 10.1016/j.str.2004.03.022 · DOI
  54. Wu, 2007, PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity, Science, 318, 274, 10.1126/science.1146447 · DOI · Paper page
  55. Zhang, 2012, Structure and allostery of the PKA RII tetrameric holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
  56. Zhang, 2015, An isoform-specific myristylation switch targets type II PKA holoenzymes to membranes, Structure, 23, 1563, 10.1016/j.str.2015.07.007 · DOI · Paper page
  57. Zheng, 1993, 2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor, Acta Crystallogr. D Biol. Crystallogr., 49, 362, 10.1107/S0907444993000423 · DOI · Paper page

Cited by

See all 33

Metadata

Authors
Cao, B., Lu, T.-W., Martinez Fiesco, J. A., Tomasini, M., Fan, L., Simon, S. M., Taylor, S. S., & Zhang, P.
Venue
Structure
Publisher
Elsevier BV
Published
2019-05
Volume
27
Issue
5
Pages
816-828.e4
ISSN
0969-2126
Cited by
33
References
1
Language
en
Licence
Funders
  • FNLCR
  • NIH (GM34921, 5R56CA207929)
  • Department of Defense (CA160446)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. https://app.cochat.ai/papers/10.1016/j.str.2019.03.001
The paper
Cao, B., Lu, T.-W., Martinez Fiesco, J. A., Tomasini, M., Fan, L., Simon, S. M., Taylor, S. S., & Zhang, P. (2019). Structures of the PKA RIα Holoenzyme with the FLHCC Driver J-PKAcα or Wild-Type PKAcα. Structure. https://doi.org/10.1016/j.str.2019.03.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.